DURHAM, N.C., Jan. 26, 2016 /PRNewswire/ -- Schulman IRB, the industry-leading central IRB in customer service and technology, is pleased to announce that Julie Blasingim, Director of Operations, recently joined the executive committee for the North Carolina Regulatory Affairs Forum (NCRAF).
"I'm looking forward to being a part of NCRAF's executive committee," said Blasingim, who will serve as Vice President of Programs for NCRAF. "My goal is to bring together professionals in the RTP community to connect with others in the regulatory affairs industry. I hope that by sharing ideas and years of expertise, we can all work together to strengthen NCRAF's presence to not only its membership but the Research Triangle Park community at large."
Blasingim will hold a two-year term as the Vice President of Programs. In this position, she will be in charge of designing, planning and executing the program's events. NCRAF hosts monthly events as well as two larger events in the spring and the fall.
Located in Research Triangle Park, North Carolina, NCRAF was founded in 1992. The organization provides a local forum for members to exchange information regarding regulatory affairs activities as they apply to organizations in research, development, or manufacturing of drugs, biologics or medical devices. NCRAF is dedicated to providing education and support for the continuing professional development of its members.
About Schulman IRB
Schulman IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services –including dedicated review capabilities for all phases of research across all therapeutic areas – to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services through its joint venture partner Provision Research Compliance Services, offering comprehensive solutions to improve overall quality standards for clinical studies and data integrity, and to maximize the protection of human subjects. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).
SOURCE Schulman IRB